Wolverine Trading, LLC Liquidia Corp Put Options Transaction History

Wolverine Trading, LLC

  • $97.8 Billion
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$11.35 - $16.73 $173,655 - $255,969
-15,300 Reduced 44.74%
18,900 $278,000
Q4 2023

Feb 14, 2024
BUY
$5.77 - $12.19 $70,394 - $148,718
12,200 Added 55.45%
34,200 $411,000
Q3 2023

Nov 15, 2023
BUY
$6.27 - $8.15 $58,310 - $75,795
9,300 Added 73.23%
22,000 $139,000
Q2 2023

Aug 23, 2023
BUY
$6.63 - $9.9 $84,201 - $125,730
12,700 New
12,700 $99,000

Others Institutions Holding LQDA

# of Institutions
157
Shares Held
35.5M
Call Options Held
1.68M
Put Options Held
1.17M
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $761M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email